Showing 8381-8390 of 20878 results for "".
Multiple Choice: Customizing Insulin Therapy
https://reachmd.com/programs/diabetes-discourse/multiple-choice-customizing-insulin-therapy/5287/Multiple choices of insulin therapy have provided a decided advantage to both the healthcare provider and patient living with diabetes. What are the specific benefits of customizing insulin therapy for our patients? Join host Dr. Steven Edelman and his guest, professor of medicine at Oregon HealthDKA in Focus: What the New Consensus Means for Practice
https://reachmd.com/programs/cme/dka-new-consensus-practice/50979/If widespread use of continuous ketone monitoring (CKM) devices is to be safe and effective in reducing the occurrence of diabetic ketoacidosis (DKA), it is important to establish clear ketone thresholds which notify CKM users when action on their part is required. In preparation for availability anRedefining Durability in Wet AMD: Insights from the SOL‑1 Superiority Trial
https://reachmd.com/programs/medical-industry-feature/wet-amd-sol1-superiority-trial-durability/56418/The SOL-1 Phase 3 superiority trial compared the efficacy and safety of the investigational product OTX-TKI (axitinib intravitreal hydrogel) with aflibercept 2 mg. The primary endpoint was proportion of subjects who maintained visual acuity, defined as <15 Early Treatment Diabetic Retinopathy StuThe Future Is Biochemical
https://reachmd.com/topics/practice-development/the-future-is-biochemical/35417/This frontier is being shaped by a category I call “biochemical cues”: modalities like exosomes, peptides, growth factors, PDRN (polydeoxyribonucleotide), and other regenerative approaches, which tap into the body’s own healing and repair mechanisms to deliver profound results.Practicing Physicians Speak Out: CME As We Need It - Part One
https://reachmd.com/programs/lifelong-learning/practicing-physicians-speak-out-cme-as-we-need-it-part-one/6032/When CME content is designed and developed, it is based on educational needs assessments. But needs vary across the spectrum of physicians and types of practices they engage in. What kind of CME is most needed? What are the shortcomings of current delivery modes, as well as CME types? How can theyLife for a Child
https://reachmd.com/programs/clinicians-roundtable/life-for-a-child/1844/Join Dr. Graham Ogle from Sydney, Australia, as he discusses the International Diabetes Federation Life for a Child Program.ILLUMIN-8: Real-World Outcomes with Aflibercept 8 Mg in DME
https://reachmd.com/programs/eye-on-ocular-health/illumin-8-real-world-outcomes-with-aflibercept-8-mg-in-dme/60931/The ILLUMIN-8 study evaluated real-world use of aflibercept 8 mg for diabetic macular edema (DME) using data from the American Academy of Ophthalmology IRIS Registry. Hear Dr. Michael Klufas review the study's findings, including treatment interval extension, visual acuity outcomes, and how these reRewriting the Calcium Code in ADH1
https://reachmd.com/programs/cme/rewriting-the-calcium-code-in-adh1/54833/Explore CALIBRATE findings and ENDO 2026 updates on mechanism-based therapy and evolving management strategies for autosomal dominant hypocalcemia type 1.Epinephrine Evolution: New Developments in Food Allergy Treatment
https://reachmd.com/programs/frontlines-food-allergies/epinephrine-evolution-new-developments-in-food-allergy-treatment/26316/Here’s how nasal and sublingual epinephrine may help address some of the common challenges associated with the traditional injection type.Anemia in the Long Term Care Setting
https://reachmd.com/programs/advances-in-long-term-care-medicine/anemia-in-the-long-term-care-setting/4356/What are the various types of anemia found in long-term care settings, and which types are the most common? What are some of the underlying causes of both chronic and acute anemia? Dr. Charles Cefalu, clinical professor and chief of the section of geriatric medicine at Louisiana State University Hea